Expert Opinion on Therapeutic Patents logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 21, Number 3, March 2011

< previous issue | all issues | next issue >


Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon?
pp. 287-294(8)
Authors: Macchiarulo, Antonio; Giacchèè, Nicola; Mancini, Francesca; Puxeddu, Efisio; Moretti, Fabiola; Pellicciari, Roberto


Advances in human papilloma virus vaccines: a patent review
pp. 295-309(15)
Authors: Cho, Hee-Jeong; Oh, Yu-Kyoung; Kim, Young Bong

Cathepsin S inhibitors: 2004 –– 2010
pp. 311-337(27)
Authors: Lee-Dutra, Alice; Wiener, Danielle K; Sun, Siquan

Neutrophil elastase inhibitors
pp. 339-354(16)
Authors: Groutas, William C; Dou, Dengfeng; Alliston, Kevin R

Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002 –– 2010)
pp. 381-397(17)
Authors: Calugi, Chiara; Trabocchi, Andrea; Guarna, Antonio

Small molecule HIV entry inhibitors: Part II. Attachment and fusion inhibitors: 2004 –– 2010
pp. 399-416(18)
Authors: Singh, Inder Pal; Chauthe, Siddheshwar Kisan

Annotated Patent Selections

Patent Evaluations

Quinazolin-4(3H)-ones capable of upregulating the expression of endogenous apolipoprotein A-1
pp. 431-435(5)
Authors: Wu, Jianhui; Zhao, Ming; Peng, Shiqi

< previous issue | all issues | next issue >


Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page